These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 9516073
1. Pharmacological features of an almitrine-raubasine combination. Activity at cerebral levels. Benzi G. Eur Neurol; 1998; 39 Suppl 1():31-8. PubMed ID: 9516073 [Abstract] [Full Text] [Related]
2. Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke. Li S, Long J, Ma Z, Xu Z, Li J, Zhang Z. Curr Med Res Opin; 2004 Mar; 20(3):409-15. PubMed ID: 15025850 [Abstract] [Full Text] [Related]
7. Metabolic and circulatory evaluation of cerebral ischemic accident in humans by positron emission tomography: a pilot study with almitrine-raubasine. Depresseux JC, Franck G, Van Cauwenberge H, Cattelin F. Clin Neuropharmacol; 1990 Mar; 13 Suppl 3():S40-9. PubMed ID: 2093417 [Abstract] [Full Text] [Related]
9. [Pharmacological approach to a treatment of senescence and cerebrovascular deficiencies related to hypoxia. Application to 5023 SE]. Devissaguet M. Presse Med; 1983 Mar 24; 12(13):823-9. PubMed ID: 6220330 [Abstract] [Full Text] [Related]
10. [Metabolic and blood circulation evaluation of acute ischemic cerebral accident in humans using positron emission tomography]. Depresseux JC, Franck G, Van Cauwenberge H. Presse Med; 1987 Jun 18; 16(23):1145-50. PubMed ID: 2885825 [Abstract] [Full Text] [Related]
12. Progress in understanding the pathophysiology of cerebral ischemia: the almitrine-raubasine approach. Bentué-Ferrer D, Decombe R, Reymann JM, Schatz C, Allain H. Clin Neuropharmacol; 1990 Jun 18; 13 Suppl 3():S9-25. PubMed ID: 2093421 [Abstract] [Full Text] [Related]
13. [The influence of aging on cerebral energy metabolism following post-hypoglycemic recovery in the rat. Pharmacologic application]. Villa RF, Pastoris O. J Pharmacol; 1986 Jun 18; 17(4):623-36. PubMed ID: 3560973 [Abstract] [Full Text] [Related]
14. Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study. Poitrenaud J, Piette F, Malbezin M, Sebban C, Guez D. Clin Neuropharmacol; 1990 Jun 18; 13 Suppl 3():S100-8. PubMed ID: 2093414 [Abstract] [Full Text] [Related]
15. Memory disorders in 8,037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine-raubasine. Poitrenaud J, Laurent B, Sebban C. Eur Neurol; 1995 Jun 18; 35 Suppl 1():43-6. PubMed ID: 8529729 [No Abstract] [Full Text] [Related]
18. [Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise]. Sebban C, Berthaux P. Presse Med; 1983 Mar 24; 12(13):847-8. PubMed ID: 6220334 [Abstract] [Full Text] [Related]
19. Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study. Carbonin PU, Greco A, Pisanti P, Gemma A, Cattelin F. Clin Neuropharmacol; 1990 Mar 24; 13 Suppl 3():S92-9. PubMed ID: 2093422 [Abstract] [Full Text] [Related]
20. [Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo]. Rapisarda V, Azzaro E, Fichera G. Presse Med; 1987 Jun 18; 16(23):1163-6. PubMed ID: 2885827 [Abstract] [Full Text] [Related] Page: [Next] [New Search]